World's Best Scientists 2026 revealed!
Bernhard Lämmle

Bernhard Lämmle

D-Index & Metrics

Medicine

D-Index
78
Citations
25174
World Ranking
17950
National Ranking
277

Overview

Bernhard Lämmle is affiliated with the University of Bern in Switzerland. Their research primarily focuses on medicine, with significant contributions to immunology and microbiology. Within these fields, they have worked extensively on subfields such as immunology, hematology, genetics, nephrology, and infectious diseases.

Their scientific work covers various topics including:

  • Complement system in diseases
  • Coagulation, bradykinin, polyphosphates, and angioedema
  • Platelet disorders and treatments
  • Renal diseases and glomerulopathies
  • Blood coagulation and thrombosis mechanisms
  • Blood groups and transfusion
  • Iron metabolism and disorders

Lämmle has published numerous papers in noted scientific journals. Recent publications include:

  • Severe COVID-19 infection associated with endothelial activation (2020), published in Thrombosis Research
  • Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management (2021), published in Journal of Clinical Medicine
  • Redefining outcomes in immune TTP: an international working group consensus report (2021), published in Blood
  • Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis (2020), published in Thrombosis and Haemostasis
  • ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients (2020), published in Thrombosis Research

Lämmle has collaborated frequently with several co-authors including Heidi Rossmann, Masanori Matsumoto, Paul Coppo, Kazuya Sakai, and György Sinkovits.

The scholar's research is regularly published in specialized venues such as Blood, Hämostaseologie, Journal of Thrombosis and Haemostasis, Journal of Clinical Medicine, and Research and Practice in Thrombosis and Haemostasis.

Best Publications

  • von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

    Miha Furlan;Rodolfo Robles;Miriam Galbusera;Giuseppe Remuzzi

  • Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis

    Miha Furlan;Rodolfo Robles;Bernhard Lammle

  • ADAMTS13 activity in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

    Sara K. Vesely;James N. George;Bernhard Lämmle;Jan Dirk Studt

  • Deficient Activity of von Willebrand Factor–Cleaving Protease in Chronic Relapsing Thrombotic Thrombocytopenic Purpura

    Miha Furlan;Rodolfo Robles;Max Solenthaler;Max Wassmer

  • Survival and relapse in patients with thrombotic thrombocytopenic purpura.

    Johanna A. Kremer Hovinga;Sara K. Vesely;Deirdra R. Terrell;Bernhard Lämmle

  • Partial amino acid sequence of purified von Willebrand factor-cleaving protease.

    Helena E. Gerritsen;Rodolfo Robles;Bernhard Lämmle;Miha Furlan

  • Acquired Deficiency of von Willebrand Factor-Cleaving Protease in a Patient With Thrombotic Thrombocytopenic Purpura

    Miha Furlan;Rodolfo Robles;Max Solenthaler;Bernhard Lämmle

  • von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models

    Alexander Brill;Alexander Brill;Tobias A. Fuchs;Tobias A. Fuchs;Anil K. Chauhan;Anil K. Chauhan;Janie J. Yang

  • Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy : results of a consensus process by an International Working Group

    Tapani Ruutu;Giovanni Barosi;Richard J. Benjamin;Richard E. Clark

  • Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)

    Helena E. Gerritsen;Peter L. Turecek;Hans P. Schwarz;Bernhard Lämmle

  • Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura.

    Valentina Bianchi;Rodolfo Robles;Lorenzo Alberio;Miha Furlan

  • Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.

    M Scully;S Cataland;P Coppo;J de la Rubia

  • Severe COVID-19 infection associated with endothelial activation.

    Robert Escher;Neal Breakey;Bernhard Lämmle

  • The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency.

    D. R. Terrell;L. A. Williams;S. K. Vesely;B. Lämmle

  • ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases

    Manfred Rieger;Pier Mannuccio Mannucci;Johanna A. Kremer Hovinga;Andrea Herzog

  • Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease

    Miha Furlan;Bernhard Lämmle

  • Thrombotic thrombocytopenic purpura

    Johanna Anna Kremer Hovinga;Paul Coppo;Bernhard Lämmle;Joel L Moake

  • Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13)

    Barbara Plaimauer;Klaus Zimmermann;Dirk Völkel;Gerhard Antoine

  • Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies

    Tobias A. Fuchs;Tobias A. Fuchs;Johanna A. Kremer Hovinga;Daphne Schatzberg;Denisa D. Wagner;Denisa D. Wagner

  • Elevated nucleosome levels in systemic inflammation and sepsis.

    Sacha Zeerleder;Bas Zwart;Walter A. Wuillemin;Lucien A. Aarden

Frequent Co-Authors

James N. George
James N. George University of Oklahoma Health Sciences Center
Nicolas Rodondi
Nicolas Rodondi University of Bern
John H. Griffin
John H. Griffin Scripps Research Institute
Karl J. Lackner
Karl J. Lackner Johannes Gutenberg University of Mainz
Henri Bounameaux
Henri Bounameaux University of Geneva
Jacques Cornuz
Jacques Cornuz University Center for General Medicine and Public Health (Unisanté)
Reinhard Schneppenheim
Reinhard Schneppenheim Universität Hamburg
Bernd R. Binder
Bernd R. Binder Medical University of Vienna
Hans Peter Schwarz
Hans Peter Schwarz Baxter (United States)
Denisa D. Wagner
Denisa D. Wagner Boston Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

A career in medicine isn’t limited to becoming a physician. Numerous online programs now offer accessible and flexible routes into related fields, each with its own set of opportunities and requirements. For those seeking career advancement, many professionals are turning to the most affordable online dnp programs to achieve a Doctor of Nursing Practice and assume leadership roles in healthcare.

Pharmacy is another dynamic path, with options such as pharmacy school online accredited programs, allowing students to train remotely while meeting industry accreditation standards. If you're interested in the intersection of healthcare and information technology, pursuing a him bachelor's degree online can open doors to roles in health data management and informatics.

Entry-level opportunities also exist through short, career-oriented courses. For those focusing on the administrative side of healthcare, you might consider enrolling in a low cost medical coding and billing online program, equipping you with skills to handle vital billing and insurance documentation processes.

Best Scientists Citing Bernhard Lämmle

Trending Scientists